ARCHIVES

1.7% Cut Expected in NCI Budget Under Deficit Agreement

This article is from The Cancer Letter archive.

Vol. 15 No. 45 | November 24, 1989

Download PDF Visit The Full Archive

Related Articles

Ovarian Suppression Treatment Plus Tamoxifen Can Lower Recurrence Risk

December 26, 2014

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

ASCO, COA Present Plans For Cancer CareBeyond the Fee-For-Service Pay Structure

January 24, 2014

Minority CCOP Applications Not Yet Reviewed

December 15, 1989

Major Emphasis Switch; Outreach Core Support Ends In Favor Of Cancer Control Research

January 22, 1982

In Brief: NCI Scientist Accused Of Taking ‘Payoffs’ Forom Drug Firms; GM-CS Wins FDA Approval

March 15, 1991